BIO vs WTW · rev $651.0M vs P/E 15, rev $4.88B
BIO (BIO) versus Willis Towers Watson PLC (WTW) — a side-by-side from cached financials, not a winner call.
BIO (BIO) common stock.
Willis Towers Watson PLC (WTW) is a insurance brokers company listed on NASDAQ.
Latest reported BIO revenue for 2026-06-30 was $651.0M. Net income was $371.4M. Revenue was up 9.9% from 2026-03-31 to 2026-06-30. BIO currently screens at market cap $0.
Latest reported WTW revenue for 2026-06-30 was $4.88B. Net income was $526.0M. WTW currently screens at market cap $24.41B and trailing P/E 15.2.
BIO currently screens at market cap $0. WTW currently screens at market cap $24.41B and trailing P/E 15.2.
Not investment advice. Open the BIO and WTW stock pages for the full models.
Not investment advice.